Cited by 13Extracellular vesicles in diseaseNanoparticle-Based Drug DeliveryCellular transport and secretion

Exosome: The “Off-the-Shelf” Cellular Nanocomponent as a Potential Pathogenic Agent, a Disease Biomarker, and Neurotherapeutics

Open access
Ghosh, Satyajit, Ghosh, Surajit·2022·Frontiers in Pharmacology

Abstract

Exosomes are nanosized "off-the-shelf" lipid vesicles released by almost all cell types and play a significant role in cell-cell communication. Exosomes have already been proven to carry cell-specific cargos of proteins, lipids, miRNA, and noncoding RNA (ribonucleic acid). These vesicles can be selectively taken up by the neighboring cell and can regulate cellular functions. Herein, we have discussed three different roles of exosomes in neuroscience. First, we have discussed how exosomes play the role of a pathogenic agent as a part of cell-cell communication and transmit pathogens such as amyloid-beta (Aβ), further helping in the propagation of neurodegenerative and other neurological diseases. In the next section, the review talks about the role of exosomes in biomarker discovery in neurological disorders. Toward the end, we have reviewed how exosomes can be harnessed and engineered for therapeutic purposes in different brain diseases. This review is based on the current knowledge generated in this field and our comprehension of this domain.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fphar.2022.878058

Cites

227 of 227 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Exosome carriers open a promising possibility to deliver therapeutic substances to treat central neurological diseases such as neurodegenerative diseases and strokes.

    “Therefore, it opens up a promising possibility to deliver therapeutic substances to treat central neurological diseases, such as neurodegenerative diseases, strokes, etc. [63].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Ghosh, S., & Ghosh, S.
Affiliations
Indian Institute of Technology Jodhpur (IN)
Corresponding author
Ghosh, Surajit
Venue
Frontiers in Pharmacology
Published
2022-05-24
Volume
13
Pages
878058-878058
ISSN
1663-9812 (ISSN-L)
OpenAlex
W4281397397
Cited by
13
References
227
Citations by year
2026: 2 · 2025: 4 · 2024: 3 · 2023: 2 · 2022: 2
FWCI
0.29
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Pharmacology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
Keywords
exosomes, extracellular vesicles, intercellular communication, amyloid-beta, neurodegenerative diseases, neurological disorders, disease biomarkers, exosome engineering, neurotherapeutics, microRNA, non-coding RNA, lipid vesicles

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review